Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

Sep 21, 2023

BUY
$76.38 - $86.03 $4.48 Million - $5.04 Million
58,600 Added 1723.53%
62,000 $5.23 Million
Q1 2021

May 14, 2021

BUY
$76.38 - $86.03 $4.48 Million - $5.04 Million
58,600 Added 1723.53%
62,000 $5.23 Million
Q4 2020

Sep 21, 2023

BUY
$75.39 - $82.36 $256,326 - $280,024
3,400 New
3,400 $272,000
Q2 2020

Nov 02, 2020

BUY
$78.66 - $94.14 $267,444 - $320,076
3,400 New
3,400 $293,000
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $936,054 - $1.12 Million
-11,900 Closed
0 $0
Q1 2020

Nov 24, 2020

BUY
$71.57 - $93.3 $851,682 - $1.11 Million
11,900 New
11,900 $978,000
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $994,822 - $1.3 Million
-13,900 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$76.7 - $88.45 $299,130 - $344,955
3,900 Added 39.0%
13,900 $1.16 Million
Q3 2019

Nov 13, 2019

BUY
$81.4 - $89.78 $480,260 - $529,702
5,900 Added 143.9%
10,000 $875,000
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $2.53 Million - $3.19 Million
-39,200 Reduced 90.53%
4,100 $333,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $589,920 - $746,880
9,600 Added 28.49%
43,300 $2.85 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $1.36 Million - $1.5 Million
-19,300 Reduced 36.42%
33,700 $2.6 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $2.86 Million - $3.4 Million
45,100 Added 570.89%
53,000 $3.91 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $5.45 Million - $6.29 Million
-87,100 Reduced 91.68%
7,900 $514,000
Q4 2017

Feb 14, 2018

SELL
$61.45 - $66.05 $2.57 Million - $2.76 Million
-41,800 Reduced 30.56%
95,000 $6.14 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $8.14 Million - $8.84 Million
136,800
136,800 $8.58 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.